跳至主要内容
临床试验/NCT06235008
NCT06235008尚未招募不适用

PAthwAy of Dyspneic patIent in Emergency in the North-east Region

Pr. Nicolas GIRERD1 个研究点 分布在 1 个国家目标入组 75,000 人开始时间: 2024年3月31日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
75,000
试验地点
1
主要终点
All-cause mortality

研究概览

简要总结

This is an observational retrospective multi-center study in patients managed for acute dyspnea by Emergency department medical team.

The main aim of the study is to evaluate factors associated with mortality risks in patients managed for acute dyspnea by an Emergency department medical team, overall, as well as in subgroups of interest (male/female, age categories, mode of admission and comorbidities).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Man or women ≥ 18 years
  • Patients with acute dyspnea cared by a medical team of the emergencies of CHRU of Nancy, CHR Metz-Thionville and CH d'Epinal.

排除标准

  • Cardiorespiratory arrest before medical management by the Emergency Department team
  • Adults under legal protection

结局指标

主要结局

All-cause mortality

时间窗: Within 5 years following hospital discharge

次要结局

  • Administration of non-invasive ventilation(Within hospital stay, maximum 21 days)
  • Readmissions (all-cause and related to acute dyspnea) to the emergency department(Within 5 years after admission)
  • Main diagnosis during the initial hospitalization(Within hospital stay, maximum 21 days)
  • Timing of non-invasive ventilation(Within hospital stay, maximum 21 days)
  • Timing of diuretics(Within hospital stay, maximum 21 days)
  • Post emergency admission(Within hospital stay, maximum 21 days)
  • All-cause hospital mortality(Within hospital stay, maximum 30 days)
  • Mismatch between diagnosis in the Emergency department and at discharge(Within hospital stay, maximum 21 days)
  • Length of hospital stay(Within hospital stay, maximum 21 days)
  • Administration of diuretics(Within hospital stay, maximum 21 days)
  • Congestion score(Within 2 days of admission)

研究者

发起方
Pr. Nicolas GIRERD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Pr. Nicolas GIRERD

Clinical Professor

Central Hospital, Nancy, France

研究点 (1)

Loading locations...

相似试验